Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.

[1]  F. Eberli,et al.  Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? , 1999, Journal of the American College of Cardiology.

[2]  C. Seiler,et al.  Adenosine-induced preconditioning of human myocardium? , 1998, Circulation.

[3]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[4]  E. Braunwald,et al.  Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. , 1998, Circulation.

[5]  D. Vaughan,et al.  Angiotensin-converting enzyme inhibitors. , 1998, Circulation.

[6]  R. Bolli,et al.  Adenosine preconditions against ischemia-induced systolic and diastolic dysfunction during percutaneous coronary angioplasty , 1998 .

[7]  C. Seiler,et al.  ADENOSINE-INDUCED PRECONDITIONING OF HUMAN MYOCARDIUM? AUTHORS' REPLY , 1998 .

[8]  M. Hori,et al.  Different mechanisms of ischemic adaptation to repeated coronary occlusion in patients with and without recruitable collateral circulation. , 1997, Journal of the American College of Cardiology.

[9]  W. Laskey,et al.  Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence. , 1997, Journal of the American College of Cardiology.

[10]  F. Crea,et al.  Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning. , 1997, Circulation.

[11]  J. Papp,et al.  Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. , 1997, The American journal of cardiology.

[12]  R. Bolli,et al.  Preconditioning of human myocardium with adenosine during coronary angioplasty. , 1997, Circulation.

[13]  S. Morris,et al.  Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. , 1997, Journal of the American College of Cardiology.

[14]  後藤真彦.  Role of bradykinin in protection of ischemic preconditioning in rabbit hearts(家兎心のプレコンディシュニングにおけるブラジキニンの役割) , 1997 .

[15]  K. Ytrehus,et al.  Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. , 1996, Journal of molecular and cellular cardiology.

[16]  K. Shimamoto,et al.  Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation. , 1996, Journal of the American College of Cardiology.

[17]  J. Downey,et al.  Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. , 1996, Journal of molecular and cellular cardiology.

[18]  F. Crea,et al.  Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. , 1996, European heart journal.

[19]  C. Vrints,et al.  Aminophylline inhibits adaptation to ischaemia during angioplasty. Role of adenosine in ischaemic preconditioning. , 1996, European heart journal.

[20]  R. Bolli,et al.  Adenosine preconditions human myocardium during PTCA , 1996 .

[21]  W. Linz,et al.  Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies , 1996, Diabetes.

[22]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[23]  R. McIntyre,et al.  Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. , 1995, The American journal of physiology.

[24]  J. Bartunek,et al.  Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. , 1995, Journal of the American College of Cardiology.

[25]  M. Cohen,et al.  Preconditioning During Ischemia: Basic Mechanisms and Potential Clinical Applications , 1995 .

[26]  J. Papp,et al.  Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors , 1994, British journal of pharmacology.

[27]  G. Lamas,et al.  Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. , 1994, Circulation.

[28]  R. Kloner,et al.  Does ischemic preconditioning occur in patients? , 1994, Journal of the American College of Cardiology.

[29]  T. Ehring,et al.  Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. , 1994, Circulation.

[30]  T. Wall,et al.  Role of bradykinin in myocardial preconditioning. , 1994, The Journal of pharmacology and experimental therapeutics.

[31]  F. Crea,et al.  Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker , 1994, Circulation.

[32]  P. Toutouzas,et al.  Relation between changes in blood flow of the contralateral coronary artery and the angiographic extent and function of recruitable collateral vessels arising from this artery during balloon coronary occlusion. , 1994, Journal of the American College of Cardiology.

[33]  J. Parratt.  Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. , 1994, Trends in pharmacological sciences.

[34]  F. Crea,et al.  Mechanisms of cardiac pain during coronary angioplasty. , 1993, Journal of the American College of Cardiology.

[35]  J. Papp,et al.  Prevention by an inhibitor of the l‐arginine‐nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs , 1993, British journal of pharmacology.

[36]  C. White,et al.  Can an intracoronary Doppler wire accurately measure changes in coronary blood flow velocity? , 1993, Catheterization and cardiovascular diagnosis.

[37]  C J Slager,et al.  Comparison of models for quantitative left ventricular wall motion analysis from two-dimensional echocardiograms during acute myocardial infarction. , 1993, The American journal of cardiology.

[38]  T. Hullinger,et al.  Reduction of Myocardial Infarct Size in Rabbits by Ramiprilat: Reversal by the Bradykinin Antagonist HOE 140 , 1993, Journal of cardiovascular pharmacology.

[39]  M. Kern,et al.  Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. , 1993, The American journal of cardiology.

[40]  G. Gross,et al.  Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. , 1993, The American journal of physiology.

[41]  W. Linz,et al.  Ramiprilat increases bradykinin outflow from isolated hearts of rat , 1993, British journal of pharmacology.

[42]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[43]  A. Cribier,et al.  Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. , 1992, Journal of the American College of Cardiology.

[44]  H. M. Payne,et al.  Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.

[45]  J. Downey,et al.  Intravenous Pretreatment With A1‐Selective Adenosine Analogues Protects the Heart Against Infarction , 1992, Circulation.

[46]  John Weiner,et al.  Letter to the Editor , 1992, SIGIR Forum.

[47]  J. Parratt,et al.  Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia‐induced arrhythmias in anaesthetized dogs , 1991, British journal of pharmacology.

[48]  J. Downey,et al.  Protection Against Infarction Afforded by Preconditioning is Mediated by A1 Adenosine Receptors in Rabbit Heart , 1991, Circulation.

[49]  W. Laskey,et al.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. , 1990, Circulation.

[50]  W. Linz,et al.  Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. , 1990, European journal of pharmacology.

[51]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[52]  S. Hosoda,et al.  Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. , 1987, Cardiovascular research.

[53]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[54]  J. Fleiss,et al.  Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.

[55]  E. Huskisson.  Measurement of pain. , 1974, Lancet.